What is Health Sciences Acquisitions Corporation 2 (HSAQ)?

Health Sciences Acquisitions Corporation 2 (HSAQ) is a stock in the Financial Services sector, Shell Companies industry. View full analysis on Stocks360.

What is the current price of HSAQ?

The current price of HSAQ is $13.31. Prices are updated in real time on Stocks360.

What is HSAQ's price-to-earnings (PE) ratio?

HSAQ's trailing twelve-month PE ratio is -16.04, based on current price and earnings per share data available on Stocks360.

What is HSAQ's market capitalization?

HSAQ's market capitalization is $149,233,051.00, placing it in the small-cap tier.

Health Sciences Acquisitions Corporation 2 (HSAQ)

Stock analysis · NASDAQ · Financial Services · Shell Companies

$13.31

Market Cap

$149.23M

PE (TTM)

-16.04

EPS (TTM)

N/A

Dividend Yield

0.00%

Beta

0.00

Day Range

$10.44 – $13.50

52-wk Range

$9.41 – $13.80

Avg Volume

N/A

Volume

119.61K

Health Sciences Acquisitions Corporation 2 (HSAQ) is a publicly traded company in the Financial Services sector. Latest price: $13.31. Market cap $149.23M. Trailing PE -16.04. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.

Get full analysis → Short-Term Analysis →

Proprietary Signals

Signal snapshot temporarily unavailable.

About Health Sciences Acquisitions Corporation 2

Health Sciences Acquisitions Corporation 2 currently lacks active business operations. Its primary objective is to complete a strategic business combination, such as a merger or acquisition, with one or more enterprises. These target businesses will operate within the biopharmaceutical or medical technology sectors and be located in North America or Europe. The company was established in 2020 and is headquartered in New York, New York.

Valuation

Trailing twelve months. Multiples relative to current market price.
P/E (TTM)	-16.04×
P/S (TTM)	4.67×
P/B	43954.82×
P/FCF (TTM)	-2.53×
EV / EBITDA	-8.43×
EV / Sales	4.07×
Earnings Yield	-0.01%
Free Cash Flow Yield	-39.60%

Fundamentals

Trailing twelve months. Source: financial statements via market data.
Enterprise Value	$130.09M
Revenue (TTM)	$31.98M
Net Income (TTM)	-$10.47K
Free Cash Flow (TTM)	-$61.77M
Net Debt	-$19.14M
Working Capital	$97.77M
Gross Margin	99.51%
Operating Margin	-181.36%
Net Margin	-186.30%
Return on Equity	-150.98%
Return on Invested Capital	-56.28%